Cargando…
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
In part A of this study, patients were randomised to cohorts receiving darbepoetin alfa at doses of 0.5 to 8.0 m.c.g. kg(−1) wk(−1) or to a control group receiving epoetin alfa at an initial dose of 150 U kg(−1) three times weekly. In part B, the cohorts were darbepoetin alfa 3.0 to 9.0 m.c.g. kg(−1...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364226/ https://www.ncbi.nlm.nih.gov/pubmed/12177793 http://dx.doi.org/10.1038/sj.bjc.6600465 |